Technology Solutions

Greenphire, Exostar partner on clinical research site payment solution

Friday, January 27, 2017

Greenphire, a global leader in clinical payment solutions, and Exostar, whose cloud-based solutions help companies mitigate risk and solve their identity and access challenges, have announced a partnership that facilitates the adoption, accessibility and use of clinical research site payment solutions. The partnership brings web-based Single Sign-On (SSO) functionality to Greenphire’s eClinicalGPS, creating seamless and secure access to the global clinical site payment platform.

[Read More]

Aduro Biotech licenses Stanford Neoantigen Identification Technology

Monday, January 23, 2017

Aduro Biotech, a biopharmaceutical company with three distinct immunotherapy technologies, has announced an exclusive license agreement with Stanford University for state-of-the-art neoantigen identification technology developed by Dr. Hanlee Ji, associate professor of medicine at Stanford. Aduro will leverage its proprietary live, attenuated double-deleted Listeria (LADD) immunotherapy platform to engineer personalized LADD-based cancer therapies (pLADD) encoding multiple neoantigens identified through this technology. The company plans to initially evaluate pLADD for the treatment of cancers of the gastrointestinal tract, including colorectal cancer, with a phase I clinical trial expected to be initiated in 2017.  

[Read More]

BASF, Nuritas partner on peptide ingredients through artificial intelligence

Monday, January 23, 2017

BASF Human Nutrition and Nuritas have announced a collaboration that will see the commercialization and discovery of health-benefiting bioactive peptide networks within specific target areas of significant value. Peptides are biologically occurring short chains of amino acids that act as potent signaling molecules in the body. The peptide networks of focus in this collaboration are natural, food-derived, patented and of significant benefit to the health of consumers. These health benefits include for example anti-inflammatory activities. 

[Read More]

FDA, IBM partner on the secure exchange of clinical data

Monday, January 23, 2017

Secure storage and controlled access to sensitive patient data are critical aspects of the clinical trial process. Investigators may need to access huge data sets shared across national and international sites. The amount and sheer number of types of data is rapidly increasing as the use of mobile and wearable devices and the querying of genomic databases are incorporated into trial design.

[Read More]